Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 197 results for "claris lifesciences"

BRIEF-Claris Lifesciences seeks members' nod for sale/transfer...

n"Jan 17 Claris Lifesciences Ltd * Seeks members' nod for sale, transfer of 'injectables business' carried on by the company in India and overseas for $625 million Source text: Further Reuters UK, 5 days ago
Claris Lifesciences: Outcome of board meeting Money Control, 1 month ago

16 images for claris lifesciences, 1 month ago, 1 month ago
FiercePharma, 1 month ago
Calcutta Telegraph, 1 month ago
Asian Venture Capital Journal, 1 month ago, 1 month ago, 1 month ago, 1 month ago
Post Online Media, 1 month ago, 4 months ago

World Organ Preservation Solutions Market 2013 2019; Research Methodology

Transparency Market Research Report Added Organ Preservation Solutions Market to its database. Albany, NY — ( SBWIRE ) — 01/18/2017 — Global Organ Preservation Solutions Market: Snapshot The global market for organ preservation solutions ...
 SSUChronicle.com4 days ago Organ Preservation Solutions Market USD 225 Million by 2020  BioPharma Dive1 month ago

Baxter to buy Claris Lifesciences global generic injectables business

The $ 625 mn deal is a move to boost Baxter's presence in this space Claris Lifesciences recently announced that it has entered into definitive agreements with Baxter International for the sale of its global generic injectables business for a ...
 Express Pharma1 month ago Baxter bags India's Claris to beef up sterile injectables biz  FiercePharma1 month ago Baxter to Acquire Claris Injectables  Pharmacy Times1 month ago Veritas, Luthra, Herbert, Latham lead on Claris sale of generic injectables biz to Baxter for $625 million  Bar & Bench1 month ago

Investors turn cold to Claris Lifesciences windfall

Claris Lifesciences deal to sell its injectables business to Baxter is not a surprise but concerns about regulatory issues may have affected its share price How much is a significant majority could be one question on the minds of shareholders of ...
 Livemint.com1 month ago Baxter's $650 Million Buy Is a Booster Shot  Equilibrio Informativo1 month ago Movers & shakers Claris Lifesciences Cools After Early Rally  Bloomberg-Quint1 month ago Claris Lifesciences surges 20% after selling subsidiary for Rs 4,237 crore  Economic Times1 month ago

Claris Lifesciences weighing buyback, dividend

Management may also decide to de-list the firm
 Business Standard1 month ago Claris Lifesciences shares rise as much as 20% on Baxter deal  Livemint.com1 month ago Baxter Deal Cheer Short-Lived: Claris Stock Falls On Regulatory Risks  Bloomberg-Quint1 month ago Claris Lifesciences shares gain 20% on Baxter deal  HT Syndication1 month ago

Claris Life hits record high but pares most gains over regulatory concerns

Mumbai: Shares of Claris Lifesciences gave up almost all of their early gains on Friday as investor optimism was dampened by concern over possible regulatory hurdles in the Claris Lifesciences-Baxter deal. The stock, which had soared as much as ...
 Economic Times1 month ago Claris Lifesciences hits record high on sale of injectables biz to Baxter  Smart Investor1 month ago

Claris Lifesciences consolidated net profit rises 169.92% in the September 2016 quarter

Sales decline 0.65% to Rs 192.13 crore
 Business Standard1 month ago Claris Lifesciences reports standalone net profit of Rs 5.01 crore in the September 2016 quarter  Business Standard1 month ago

Herbert Smith Freehills advises Claris Lifesciences on the sale of its US$625 million global generic injectables business

Herbert Smith Freehills has advised new client Claris Lifesciences Limited on the sale of its global generic injectables business Claris Injectables for US$625 million to Baxter International Inc.. Claris Injectables, a wholly-owned subsidiary of ...
 Legal Monitor1 month ago Claris Lifesciences jumps after selling its global generic injectables business  Business Standard1 month ago

Claris Lifesciences zooms 20% on sale of injectables biz to Baxter

» » » Shares of Claris Lifesciences rallied nearly 20%, hitting 52-week high, on the BSE after the pharma major said that it will sell its global Generic Injectables Business to Baxter for USD 625 million. Updated: Friday, December 16, ...
 Oneindia1 month ago Claris Life hits new high, up 20% on sale of injectable biz  Money Control1 month ago Claris at new high, up 20% on sale of injectable biz to Baxter  Money Control1 month ago

In the spotlight Stocks To Watch: Claris Lifesciences, Dilip Buildcon, Saksoft And More

Bloomberg | Quint is a multiplatform, Indian business and financial news company. We combine Bloomberg's global leadership in business and financial news and data, with Quintillion Media's deep expertise in the Indian market and digital news ...
 Bloomberg-Quint1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less